Case Studies > GluMetrics, Inc.

dapCS is working in partnership with academia and the healthcare industry to bring glucose sensing technology to the marketplace in the area of diabetes management and hospital intensive care. We participated in the formation and funding of GluMetrics, Inc. (formerly GluMetrics, LLC) to shepherd this effort from an academic research project to a life-saving healthcare product. GluMetrics was founded by an academician who has worked with AdapCS in building a company that can meet the needs of this exciting partnership between academia and industry. GluMetrics, Inc. is composed of investors, academic and industrial researchers and administrative staff, totaling over 15 professionals in all.

In UCSC's Department of Chemistry, Professor Bakthan Singaram and his research team developed a unique substance that glows in the presence of sugar. This boron-based polymeric material is GluMetrics' core technology, and is capable of detecting and measuring the blood sugar level of hospitalized patients and diabetics in a way that will enable physicians to deliver higher quality care than has ever before been achieved. This substance has long been sought after as the "missing link" in the development of an artificial pancreas, which is likely to be the next major breakthrough in bionic physiology.

GluMetrics represents a very real opportunity for investors, researchers and entrepreneurs to do what they do best - create value - and to enjoy the rewards they deserve in bringing this marvelous advancement into the everyday lives of diabetics and others world wide. AdapCS is proud to be a part of that effort. For more information visit the GluMetrics website at www.glumetrics.com.